Insider Transactions Reported by 14 Insiders of Ovid Therapeutics Inc.

Symbol
OVID on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Ovid Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
TAKEDA PHARMACEUTICAL CO LTD 10%+ Owner $11,680,054 08 Dec 2025
JEREMY M. LEVIN Director $5,584,763 26 Feb 2026
Amit Rakhit President and CMO $1,562,669 14 Jul 2021
Jeffrey A. Rona Cbfo $237,595 -$12,384 -5% 23 Feb 2026
STELIOS PAPADOPOULOS Director $112,000 26 Feb 2026
MARGARET A. ALEXANDER President and CEO, Director $89,537 -$16,901 -16% 23 Feb 2026
Jason Tardio Chief Operating Officer $60,469 22 Feb 2024
Thomas Michael Perone General Counsel, Secretary $60,469 22 Feb 2024
Kevin Joseph Fitzgerald Director 26 Feb 2026
Robert Michael Poole Director 22 Feb 2024
DOUGLAS E. WILLIAMS Director 17 May 2021
Bart Friedman Director 26 Feb 2026
Karen Bernstein Director 26 Feb 2026
Barbara Gayle Duncan Director 26 Feb 2026

Recent Insider Transactions by Companies or Individuals for Ovid Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
MARGARET A. ALEXANDER OVID Employee Stock Option (Right to Buy) Award 1,435,000 1,435,000 26 Feb 2026 Direct
STELIOS PAPADOPOULOS OVID Employee Stock Option (Right to Buy) Award 65,000 65,000 26 Feb 2026 Direct
Kevin Joseph Fitzgerald OVID Employee Stock Option (Right to Buy) Award 65,000 65,000 26 Feb 2026 Direct
JEREMY M. LEVIN OVID Employee Stock Option (Right to Buy) Award 957,000 957,000 26 Feb 2026 Direct
Bart Friedman OVID Employee Stock Option (Right to Buy) Award 65,000 65,000 26 Feb 2026 Direct
Barbara Gayle Duncan OVID Employee Stock Option (Right to Buy) Award 65,000 65,000 26 Feb 2026 Direct
Karen Bernstein OVID Employee Stock Option (Right to Buy) Award 65,000 65,000 26 Feb 2026 Direct
Jeffrey A. Rona OVID Common Stock Award 77.2% 68,125 156,313 26 Feb 2026 Direct
Jeffrey A. Rona OVID Employee Stock Option (Right to Buy) Award 408,750 408,750 26 Feb 2026 Direct
MARGARET A. ALEXANDER OVID Common Stock Sale -15.9% $16,901 $1.45 -11,656 61,750 23 Feb 2026 Direct
Jeffrey A. Rona OVID Common Stock Sale -8.83% $12,384 $1.45 -8,541 88,188 23 Feb 2026 Direct
MARGARET A. ALEXANDER OVID Employee Stock Option (right to buy) Award 890,000 890,000 04 Jan 2026 Direct
JEREMY M. LEVIN OVID Common Stock Conversion of derivative security 1.96% 71,000 3,687,715 15 Dec 2025 Direct
JEREMY M. LEVIN OVID Series B Convertible Preferred Stock Conversion of derivative security -100% -71 0 15 Dec 2025 Direct
JEREMY M. LEVIN OVID Series B Warrant (right to buy) Purchase 35,500 35,500 11 Dec 2025 Direct
JEREMY M. LEVIN OVID Series A Warrant (right to buy) Purchase 47,333 47,333 11 Dec 2025 Direct
JEREMY M. LEVIN OVID Series B Convertible Preferred Stock Purchase 71 71 11 Dec 2025 Direct
Takeda Pharmaceutical Co Ltd OVID Common Stock Conversion of derivative security 21.7% 1,250,000 7,000,000 08 Dec 2025 See Explanation of Responses
Takeda Pharmaceutical Co Ltd OVID Series A Convertible Preferred Stock Conversion of derivative security -100% -1,250 0 08 Dec 2025 See Explanation of Responses
STELIOS PAPADOPOULOS OVID Stock Option (right to buy) Award 90,000 90,000 03 Mar 2025 Direct
MARGARET A. ALEXANDER OVID Common Stock Sale -6.71% $2,956 $0.5600 -5,279 73,406 26 Feb 2025 Direct
Jeffrey A. Rona OVID Common Stock Sale -5.43% $2,185 $0.5600 -3,902 67,973 26 Feb 2025 Direct
Kevin Joseph Fitzgerald OVID Stock Option (right to buy) Award 45,000 45,000 20 Feb 2025 Direct
Bart Friedman OVID Stock Option (right to buy) Award 45,000 45,000 20 Feb 2025 Direct
Barbara Gayle Duncan OVID Stock Option (right to buy) Award 45,000 45,000 20 Feb 2025 Direct
Karen Bernstein OVID Stock Option (right to buy) Award 45,000 45,000 20 Feb 2025 Direct
JEREMY M. LEVIN OVID Employee Stock Option (Right to Buy) Award 1,650,000 1,650,000 20 Feb 2025 Direct
Jeffrey A. Rona OVID Common Stock Award 155.6% 43,750 71,875 20 Feb 2025 Direct
Jeffrey A. Rona OVID Employee Stock Option (Right to Buy) Award 262,500 262,500 20 Feb 2025 Direct
MARGARET A. ALEXANDER OVID Common Stock Award 125.2% 43,750 78,685 20 Feb 2025 Direct
MARGARET A. ALEXANDER OVID Employee Stock Option (Right to Buy) Award 262,500 262,500 20 Feb 2025 Direct
MARGARET A. ALEXANDER OVID Common Stock Purchase 24.2% $4,971 $0.7300 6,810 34,935 27 Jan 2025 Direct
Kevin Joseph Fitzgerald OVID Stock Option (Right to Buy) Award 90,000 90,000 12 Dec 2024 Direct
Bart Friedman OVID Stock Option (Right to Buy) Award 90,000 90,000 12 Dec 2024 Direct
Barbara Gayle Duncan OVID Stock Option (Right to Buy) Award 90,000 90,000 12 Dec 2024 Direct
Karen Bernstein OVID Stock Option (Right to Buy) Award 90,000 90,000 12 Dec 2024 Direct
MARGARET A. ALEXANDER OVID Employee Stock Option (right to buy) Award 140,000 140,000 09 Sep 2024 Direct
Jeffrey A. Rona OVID Employee Stock Option (right to buy) Award 315,000 315,000 30 Jul 2024 Direct
JEREMY M. LEVIN OVID Common Stock Purchase 0.51% $50,364 $2.76 18,248 3,616,715 18 Mar 2024 Direct
Jason Tardio OVID Common Stock Award 28,125 28,125 22 Feb 2024 Direct
Jason Tardio OVID Stock Option (Right to Buy) Award 168,750 168,750 22 Feb 2024 Direct
Jeffrey A. Rona OVID Common Stock Award 28,125 28,125 22 Feb 2024 Direct
Jeffrey A. Rona OVID Stock Option (Right to Buy) Award 168,750 0 22 Feb 2024 Direct
Robert Michael Poole OVID Stock Option (Right to Buy) Award 30,000 30,000 22 Feb 2024 Direct
Thomas Michael Perone OVID Common Stock Award 28,125 28,125 22 Feb 2024 Direct
Thomas Michael Perone OVID Stock Option (Right to Buy) Award 168,750 168,750 22 Feb 2024 Direct
JEREMY M. LEVIN OVID Stock Option (Right to Buy) Award 700,000 700,000 22 Feb 2024 Direct
Bart Friedman OVID Stock Option (Right to Buy) Award 30,000 30,000 22 Feb 2024 Direct
Kevin Joseph Fitzgerald OVID Stock Option (Right to Buy) Award 30,000 30,000 22 Feb 2024 Direct
Barbara Gayle Duncan OVID Stock Option (Right to Buy) Award 30,000 30,000 22 Feb 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.